Ein Unternehmen der RHÖN-KLINIKUM AG


Aktuelle Veröffentlichungen:

  • Ang M, Linn T. Comparison of the effects of slowly and rapidly absorbed carbohydrates on postprandial glucose metabolism in type 2 diabetes mellitus patients: a randomized trial. Am J Clin Nutr 100: 1059-68, 2014
  • Soydan N, Bretzel RG, Fischer B, Wagenlehner F, Pilatz A, Linn T. Reduced capacity of heart rate regulation in response to mild hypoglycemia induced by glibenclamide and physical exercise in type 2 diabetes. Metabolism 62: 717-724, 2013
  • Rusz A, Pilatz A, Wagenlehner F, Linn T, Diemer T, Schuppe HC, Lohmeyer J, Hossain H, Weidner W. Influence of urogenital infections and inflammation on semen quality and male fertility. World J Urol 30: 23-30, 2012
  • Ang M, Müller AS, Wagenlehner F, Pilatz A, Linn T. Combining protein and carbohydrate increases postprandial insulin levels but does not improve glucose response in patients with type 2 diabetes. Metabolism 61: 1696-1702, 2012
  • Fischer B, Elias D, Bretzel RG, Linn T: Immunomodulation with Heat shock protein DiaPep 277 to preserve beta cell function in Type 1 Diabetes – an update. Exp. Opinion on Biological Therapy, 10: 265-272, 2010
  • Bretzel RG, Dippel FW, Linn T, Neilson AR. Comparison of treatment costs in inadequately controlled type 2 diabetes in Germany based on the APOLLO trial with insulin glargine. J Med Econ. 2: 87-97, 2009
  • Bretzel RG, Eckhard M, Landgraf W, Owens DR, Linn T: Initiating insulin therapy in type 2 diabetic patients failing improvement with oral antidiabetic drugs: basal or prandial insulin ?  The APOLLO trial and beyond. Diabetes Care 32: Suppl 2: S260-S265, 2009
  • Hermanns N, Plate M, Kulzer B, Fischer B, Linn T, Bretzel R, Haak T. Effect of experimentally induced hypoglycemia and different insulin levels onfeelings of hunger in type 1 diabetic patients. Exp Clin Endocrinol Diabetes, 116: 255-61, 2008
  • Linn T, Fischer B, Soydan N, Eckhard M, Ehl J, Kunz C, Bretzel RG Nocturnal glucose metabolism after a single bedtime injection of insulin glargine or NPH insulin in patients with type 2 diabetes: a three-way, placebo-controlled study of the overnight pharmacodynamics of insulin. J Clin Endo Metab, 93: 3839-3846, 2008
  • Bretzel RG, Nuber U, Landgraf W, Owens DR, Bradley C, and Linn T for the APOLLO Study Group: Equivalence of basal insulin glargine versus prandial insulin lispro for glucose control in randomized type 2 diabetes patients on oral agents – results of the APOLLO study. Lancet, 371: 1073-1084, 2008